Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FSU77
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,200
Award facts
- Contract value 100% obligated
- $4,200.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $4,200.08 to DMS Pharmaceutical Group Inc. for Cosentyx (secukinumab) 300 mg pen injections. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received this award on October 23, 2025, with an ultimate completion date of October 24, 2025. The delivery order carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The place of performance is Park Ridge, Illinois, where the vendor is headquartered and maintains its operations.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to provide pharmaceutical supplies to military healthcare facilities worldwide. The underlying IDC, valued at $499.999 billion with a completion date of December 31, 2036, authorizes DLA to issue delivery orders for branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense medical supply requirements globally. DMS Pharmaceutical Group's established performance on numerous delivery orders positions it as a critical supplier within the federal pharmaceutical supply chain for military healthcare operations.
Quick answers
Who was awarded contract SPE2DB26FSU77?
SPE2DB26FSU77 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 23, 2025.
How much is contract SPE2DB26FSU77 worth?
The government has obligated $4,200 on SPE2DB26FSU77.
Is contract SPE2DB26FSU77 an order under another contract?
Yes. SPE2DB26FSU77 is a delivery order under SPE2DB22D9367, an indefinite delivery contract.
Was contract SPE2DB26FSU77 competed?
The extent of competition for SPE2DB26FSU77 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award